CarsonAllaria Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,196
Closed -$209K 71
2025
Q3
$209K Sell
2,196
-9
-0.4% -$827 0.11% 64
2025
Q2
$192K Sell
2,205
-76
-3% -$6.45K 0.1% 66
2025
Q1
$205K Buy
2,281
+45
+2% +$4.03K 0.12% 65
2024
Q4
$179K Sell
2,236
-193
-8% -$16.7K 0.1% 69
2024
Q3
$219K Buy
2,429
+238
+11% +$20K 0.13% 64
2024
Q2
$173K Sell
2,191
-120
-5% -$9.84K 0.11% 70
2024
Q1
$201K Sell
2,311
-208
-8% -$17.8K 0.13% 65
2023
Q4
$208K Buy
2,519
+116
+5% +$8.84K 0.15% 64
2023
Q3
$188K Sell
2,403
-113
-4% -$9.46K 0.15% 62
2023
Q2
$222K Buy
2,516
+13
+0.5% +$1.12K 0.17% 62
2023
Q1
$202K Buy
2,503
+13
+0.5% +$1.06K 0.17% 67
2022
Q4
$194K Buy
2,490
+8
+0.3% +$648 0.17% 66
2022
Q3
$200K Buy
2,482
+17
+0.7% +$1.53K 0.19% 64
2022
Q2
$221K Buy
2,465
+11
+0.4% +$1.11K 0.21% 60
2022
Q1
$272K Buy
2,454
+2,074
+546% +$219K 0.24% 53
2021
Q4
$39K Buy
+380
New +$44K 0.03% 133

Other funds holding MDT

CarsonAllaria Wealth Management's MDT Position: Q4 2025 in Review

CarsonAllaria Wealth Management sold out of Medtronic (MDT) in Q4 2025, closing a stake of 2,196 shares — an estimated $209K sold.

CarsonAllaria Wealth Management first reported a position in MDT in Q4 2021 and held it in 16 quarters. The position peaked at $272K in Q1 2022. 2,312 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • CarsonAllaria Wealth Management reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 2,196 Medtronic shares in Q4 2025, an estimated $209K.
  • CarsonAllaria Wealth Management first reported a position in Medtronic in Q4 2021 and held it in 16 quarters.
  • CarsonAllaria Wealth Management's Medtronic position peaked at $272K in Q1 2022.
  • 2,312 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on CarsonAllaria Wealth Management's 13F filing for Q4 2025, filed 22 Jan 2026.